Latest news with #LaboratoriosFarmaceuticosRovi
Yahoo
03-07-2025
- Business
- Yahoo
3 European Stocks That May Be Undervalued In July 2025
As the European markets show signs of resilience, with the STOXX Europe 600 Index climbing 1.32% amid easing geopolitical tensions and promises of economic stimulus, investors are keenly assessing opportunities in the region. Identifying undervalued stocks can be particularly appealing in such an environment, as these equities may offer potential for growth when market conditions stabilize further. Name Current Price Fair Value (Est) Discount (Est) Zaptec (OB:ZAP) NOK22.50 NOK44.90 49.9% Qt Group Oyj (HLSE:QTCOM) €57.55 €113.35 49.2% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.75 €110.26 49.4% Ion Beam Applications (ENXTBR:IBAB) €11.66 €22.99 49.3% innoscripta (XTRA:1INN) €99.30 €196.58 49.5% Honkarakenne Oyj (HLSE:HONBS) €2.70 €5.37 49.7% Green Oleo (BIT:GRN) €0.795 €1.57 49.2% Cavotec (OM:CCC) SEK17.00 SEK33.97 49.9% Archicom (WSE:ARH) PLN43.00 PLN84.73 49.2% ABO Energy GmbH KGaA (XTRA:AB9) €38.40 €76.54 49.8% Click here to see the full list of 180 stocks from our Undervalued European Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Overview: Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that manufactures, sells, and markets its products across Spain, the European Union, OECD countries, and internationally with a market cap of €2.85 billion. Operations: Laboratorios Farmaceuticos Rovi generates revenue through the manufacturing, selling, and marketing of pharmaceutical products across Spain, the European Union, OECD countries, and internationally. Estimated Discount To Fair Value: 49.4% Laboratorios Farmaceuticos Rovi is trading at €55.75, significantly below its estimated fair value of €110.26, indicating it may be undervalued based on cash flows. Analysts agree the stock price could rise by 41.8%. With earnings forecast to grow 16.5% annually—outpacing the Spanish market's 5.5%—and revenue projected to increase at 8.2%, Rovi's financial outlook remains robust despite slower-than-significant growth expectations in both earnings and revenue metrics. Insights from our recent growth report point to a promising forecast for Laboratorios Farmaceuticos Rovi's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Laboratorios Farmaceuticos Rovi. Overview: Neste Oyj, with a market cap of €9.22 billion, operates in the production and distribution of renewable diesel and sustainable aviation fuel across Finland, other Nordic countries, the Baltic Rim, Europe, the United States, and internationally. Operations: The company's revenue segments include Oil Products (€12.10 billion), Renewable Products (€7.30 billion), and Marketing & Services (€4.51 billion). Estimated Discount To Fair Value: 19.6% Neste Oyj is trading at €12, below its estimated fair value of €14.92, reflecting a modest undervaluation based on discounted cash flow analysis. Despite recent volatility and high debt levels, the company is expected to achieve profitability within three years with earnings projected to grow significantly annually. Recent developments in renewable fuel technology with Chevron Lummus Global highlight potential future revenue streams, although recent index exclusion may impact investor sentiment. According our earnings growth report, there's an indication that Neste Oyj might be ready to expand. Click here to discover the nuances of Neste Oyj with our detailed financial health report. Overview: Andritz AG is a global provider of industrial machinery, equipment, and services across various continents including Europe, North America, South America, China, Asia, Africa, and Australia with a market cap of €5.99 billion. Operations: The company generates revenue from four main segments: Metals (€1.78 billion), Hydro Power (€1.61 billion), Pulp & Paper (€3.27 billion), and Environment & Energy (€1.52 billion). Estimated Discount To Fair Value: 48.3% Andritz AG, trading at €61.5, is significantly undervalued with an estimated fair value of €118.95 based on discounted cash flow analysis. Despite a decline in first-quarter sales and net income compared to the previous year, earnings are projected to grow 11.47% annually, outpacing the Austrian market's growth rate. However, its dividend yield of 4.23% is not fully supported by free cash flows, indicating potential sustainability concerns despite strong relative value against industry peers. Our comprehensive growth report raises the possibility that Andritz is poised for substantial financial growth. Unlock comprehensive insights into our analysis of Andritz stock in this financial health report. Investigate our full lineup of 180 Undervalued European Stocks Based On Cash Flows right here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:ROVI HLSE:NESTE and WBAG:ANDR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-07-2025
- Business
- Yahoo
3 European Stocks That May Be Undervalued In July 2025
As the European markets show signs of resilience, with the STOXX Europe 600 Index climbing 1.32% amid easing geopolitical tensions and promises of economic stimulus, investors are keenly assessing opportunities in the region. Identifying undervalued stocks can be particularly appealing in such an environment, as these equities may offer potential for growth when market conditions stabilize further. Name Current Price Fair Value (Est) Discount (Est) Zaptec (OB:ZAP) NOK22.50 NOK44.90 49.9% Qt Group Oyj (HLSE:QTCOM) €57.55 €113.35 49.2% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.75 €110.26 49.4% Ion Beam Applications (ENXTBR:IBAB) €11.66 €22.99 49.3% innoscripta (XTRA:1INN) €99.30 €196.58 49.5% Honkarakenne Oyj (HLSE:HONBS) €2.70 €5.37 49.7% Green Oleo (BIT:GRN) €0.795 €1.57 49.2% Cavotec (OM:CCC) SEK17.00 SEK33.97 49.9% Archicom (WSE:ARH) PLN43.00 PLN84.73 49.2% ABO Energy GmbH KGaA (XTRA:AB9) €38.40 €76.54 49.8% Click here to see the full list of 180 stocks from our Undervalued European Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. Overview: Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that manufactures, sells, and markets its products across Spain, the European Union, OECD countries, and internationally with a market cap of €2.85 billion. Operations: Laboratorios Farmaceuticos Rovi generates revenue through the manufacturing, selling, and marketing of pharmaceutical products across Spain, the European Union, OECD countries, and internationally. Estimated Discount To Fair Value: 49.4% Laboratorios Farmaceuticos Rovi is trading at €55.75, significantly below its estimated fair value of €110.26, indicating it may be undervalued based on cash flows. Analysts agree the stock price could rise by 41.8%. With earnings forecast to grow 16.5% annually—outpacing the Spanish market's 5.5%—and revenue projected to increase at 8.2%, Rovi's financial outlook remains robust despite slower-than-significant growth expectations in both earnings and revenue metrics. Insights from our recent growth report point to a promising forecast for Laboratorios Farmaceuticos Rovi's business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Laboratorios Farmaceuticos Rovi. Overview: Neste Oyj, with a market cap of €9.22 billion, operates in the production and distribution of renewable diesel and sustainable aviation fuel across Finland, other Nordic countries, the Baltic Rim, Europe, the United States, and internationally. Operations: The company's revenue segments include Oil Products (€12.10 billion), Renewable Products (€7.30 billion), and Marketing & Services (€4.51 billion). Estimated Discount To Fair Value: 19.6% Neste Oyj is trading at €12, below its estimated fair value of €14.92, reflecting a modest undervaluation based on discounted cash flow analysis. Despite recent volatility and high debt levels, the company is expected to achieve profitability within three years with earnings projected to grow significantly annually. Recent developments in renewable fuel technology with Chevron Lummus Global highlight potential future revenue streams, although recent index exclusion may impact investor sentiment. According our earnings growth report, there's an indication that Neste Oyj might be ready to expand. Click here to discover the nuances of Neste Oyj with our detailed financial health report. Overview: Andritz AG is a global provider of industrial machinery, equipment, and services across various continents including Europe, North America, South America, China, Asia, Africa, and Australia with a market cap of €5.99 billion. Operations: The company generates revenue from four main segments: Metals (€1.78 billion), Hydro Power (€1.61 billion), Pulp & Paper (€3.27 billion), and Environment & Energy (€1.52 billion). Estimated Discount To Fair Value: 48.3% Andritz AG, trading at €61.5, is significantly undervalued with an estimated fair value of €118.95 based on discounted cash flow analysis. Despite a decline in first-quarter sales and net income compared to the previous year, earnings are projected to grow 11.47% annually, outpacing the Austrian market's growth rate. However, its dividend yield of 4.23% is not fully supported by free cash flows, indicating potential sustainability concerns despite strong relative value against industry peers. Our comprehensive growth report raises the possibility that Andritz is poised for substantial financial growth. Unlock comprehensive insights into our analysis of Andritz stock in this financial health report. Investigate our full lineup of 180 Undervalued European Stocks Based On Cash Flows right here. Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BME:ROVI HLSE:NESTE and WBAG:ANDR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Connectez-vous pour accéder à votre portefeuille
Yahoo
02-07-2025
- Business
- Yahoo
Global Market Insights Three Stocks Possibly Trading Below Estimated Value
As global markets recently celebrated record highs, driven by easing geopolitical tensions and positive trade developments, investors are keenly observing opportunities amidst fluctuating economic indicators. In such an environment, identifying stocks that might be trading below their estimated value becomes crucial for those seeking potential growth opportunities. Name Current Price Fair Value (Est) Discount (Est) SIGMAXYZ Holdings (TSE:6088) ¥1222.00 ¥2440.81 49.9% Prospect Logistics and Industrial Freehold and Leasehold Real Estate Investment Trust (SET:PROSPECT) THB7.20 THB14.38 49.9% Maxscend Microelectronics (SZSE:300782) CN¥69.87 CN¥139.67 50% Laboratorios Farmaceuticos Rovi (BME:ROVI) €55.30 €110.26 49.8% KeePer Technical Laboratory (TSE:6036) ¥3385.00 ¥6750.67 49.9% Good Will Instrument (TWSE:2423) NT$43.45 NT$86.70 49.9% Duk San NeoluxLtd (KOSDAQ:A213420) ₩33600.00 ₩67079.97 49.9% Cavotec (OM:CCC) SEK17.00 SEK33.89 49.8% América Móvil. de (BMV:AMX B) MX$16.83 MX$33.60 49.9% Almirall (BME:ALM) €10.64 €21.21 49.8% Click here to see the full list of 487 stocks from our Undervalued Global Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: Tofas Türk Otomobil Fabrikasi Anonim Sirketi manufactures and sells passenger cars and light commercial vehicles in Turkey, with a market cap of TRY101.95 billion. Operations: The company's revenue segments include Consumer Financing, generating TRY9.29 billion, and Trading of Spare Parts and Automobile, contributing TRY97.99 billion. Estimated Discount To Fair Value: 21.7% Tofas Türk Otomobil Fabrikasi Anonim Sirketi is trading at TRY 203.9, below its estimated fair value of TRY 260.36, indicating it may be undervalued based on cash flows despite recent challenges. While the company reported a net loss in Q1 2025 with sales dropping significantly year-on-year, analysts forecast robust revenue growth of 38.9% annually and earnings growth of over 71%, outpacing the Turkish market's expectations, although dividends remain unsustainable from current cash flows. Our earnings growth report unveils the potential for significant increases in Tofas Türk Otomobil Fabrikasi Anonim Sirketi's future results. Delve into the full analysis health report here for a deeper understanding of Tofas Türk Otomobil Fabrikasi Anonim Sirketi. Overview: Türk Telekomünikasyon Anonim Sirketi, along with its subsidiaries, functions as an integrated telecommunications provider in Turkey with a market capitalization of TRY214.20 billion. Operations: The company's revenue segments include Mobile at TRY70.02 billion and Fixed-Line at TRY104.54 billion. Estimated Discount To Fair Value: 17% Türk Telekomünikasyon Anonim Sirketi, priced at TRY 61.2, trades below its estimated fair value of TRY 73.73, suggesting potential undervaluation based on cash flows. The company's earnings and revenue are forecast to grow significantly faster than the Turkish market over the next three years. Despite a decline in profit margins compared to last year, Türk Telekom's innovative strides in 6G technology and strong quarterly performance bolster its growth outlook amidst evolving industry standards. Upon reviewing our latest growth report, Türk Telekomünikasyon Anonim Sirketi's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of Türk Telekomünikasyon Anonim Sirketi stock in this financial health report. Overview: Saudi Basic Industries Corporation operates globally in the manufacturing, marketing, and distribution of chemicals, polymers, plastics, and agri-nutrients with a market cap of SAR165 billion. Operations: The company's revenue segments include Agri-Nutrients at SAR11.32 billion and Petrochemicals & Specialties at SAR130.57 billion. Estimated Discount To Fair Value: 18.4% Saudi Basic Industries, priced at SAR 55.1, trades below its fair value estimate of SAR 67.56, indicating potential undervaluation based on cash flows. Despite a recent net loss and lower profit margins compared to last year, its earnings are expected to grow significantly faster than the Saudi Arabian market over the next three years. The company is exploring an IPO for its gas business amid broader operational reviews, which may influence future financial flexibility and growth strategies. The analysis detailed in our Saudi Basic Industries growth report hints at robust future financial performance. Get an in-depth perspective on Saudi Basic Industries' balance sheet by reading our health report here. Discover the full array of 487 Undervalued Global Stocks Based On Cash Flows right here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include IBSE:TOASO IBSE:TTKOM and SASE:2010. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
03-06-2025
- Business
- Yahoo
European Stocks That May Be Priced Below Their Estimated Intrinsic Values
As European markets experience a slight uptick, with the pan-European STOXX Europe 600 Index rising by 0.65% amid trade negotiations and slowing inflation, investors are keenly observing potential shifts in monetary policy from the European Central Bank. In this environment, identifying stocks that may be priced below their estimated intrinsic values can offer opportunities for those looking to capitalize on market inefficiencies and economic developments. Name Current Price Fair Value (Est) Discount (Est) Laboratorios Farmaceuticos Rovi (BME:ROVI) €53.90 €104.47 48.4% Alfio Bardolla Training Group (BIT:ABTG) €1.90 €3.70 48.6% CTT Systems (OM:CTT) SEK213.50 SEK416.33 48.7% Séché Environnement (ENXTPA:SCHP) €99.00 €197.26 49.8% Clemondo Group (OM:CLEM) SEK10.80 SEK21.25 49.2% Lectra (ENXTPA:LSS) €24.05 €47.11 49% Absolent Air Care Group (OM:ABSO) SEK214.00 SEK416.45 48.6% Trøndelag Sparebank (OB:TRSB) NOK114.50 NOK226.55 49.5% Nexstim (HLSE:NXTMH) €7.98 €15.71 49.2% VIGO Photonics (WSE:VGO) PLN522.00 PLN1042.74 49.9% Click here to see the full list of 187 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Overview: Maire S.p.A. specializes in developing and implementing solutions for the energy transition, with a market cap of €3.76 billion. Operations: The company's revenue segments consist of Integrated E&C Solutions, generating €5.97 billion, and Sustainable Technology Solutions, contributing €376.94 million. Estimated Discount To Fair Value: 35.8% Maire S.p.A. appears undervalued, trading 35.8% below its estimated fair value of €17.83, with a current price of €11.45. Recent earnings growth and a forecasted annual profit increase of 12.4% outpace the Italian market's average growth rate, despite revenue projections being modest at 5.9%. The company's recent strategic partnership with Radware enhances its cybersecurity offerings, potentially bolstering future cash flows amidst a volatile share price history and an unstable dividend track record. Our expertly prepared growth report on Maire implies its future financial outlook may be stronger than recent results. Click here and access our complete balance sheet health report to understand the dynamics of Maire. Overview: Cellnex Telecom, S.A. operates as a manager of terrestrial telecommunications infrastructures across multiple European countries including Austria, Denmark, Spain, and others, with a market cap of €23.98 billion. Operations: Cellnex Telecom generates revenue through the management of terrestrial telecommunications infrastructures across several European countries, including Austria, Denmark, Spain, and others. Estimated Discount To Fair Value: 44.1% Cellnex Telecom is trading at €33.98, significantly below its estimated fair value of €60.77, indicating it is undervalued based on cash flows. The company is forecast to achieve profitability within three years, with earnings expected to grow by 49.35% annually. Recent strategic moves include a completed share buyback worth €800 million and potential sale discussions of its Swiss business for up to €2 billion, which could influence future cash flow dynamics positively. Our earnings growth report unveils the potential for significant increases in Cellnex Telecom's future results. Click to explore a detailed breakdown of our findings in Cellnex Telecom's balance sheet health report. Overview: Thales S.A. operates globally in the defence and security, aerospace and space, and digital identity and security sectors, with a market cap of €55.48 billion. Operations: Thales generates revenue from its Aerospace segment (€5.64 billion), Cyber & Digital operations (€4.15 billion), and Defence (excluding Digital Identity & Security) activities (€11.32 billion). Estimated Discount To Fair Value: 15.8% Thales is trading at €270.2, below its estimated fair value of €321.06, showing it is undervalued based on cash flows. Earnings are forecast to grow 17.94% annually, outpacing the French market's growth rate. Recent strategic partnerships with Michelin and Deloitte enhance Thales's position in software monetization and cybersecurity services, potentially bolstering future cash flow generation while maintaining a focus on selective mergers and acquisitions for strategic expansion. Insights from our recent growth report point to a promising forecast for Thales' business outlook. Navigate through the intricacies of Thales with our comprehensive financial health report here. Delve into our full catalog of 187 Undervalued European Stocks Based On Cash Flows here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:MAIRE BME:CLNX and ENXTPA:HO. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
28-05-2025
- Business
- Yahoo
European Value Stocks Priced Below Estimated Intrinsic Worth
The European stock market has recently faced downward pressure, with the pan-European STOXX Europe 600 Index dropping by 0.75% amid heightened trade tensions following proposed tariffs from the U.S. administration. In this challenging environment, identifying stocks that are priced below their intrinsic value can offer investors potential opportunities to capitalize on market inefficiencies and position themselves for long-term gains. Name Current Price Fair Value (Est) Discount (Est) Micro Systemation (OM:MSAB B) SEK49.60 SEK96.51 48.6% Laboratorios Farmaceuticos Rovi (BME:ROVI) €52.35 €104.47 49.9% Alfio Bardolla Training Group (BIT:ABTG) €1.88 €3.70 49.2% adidas (XTRA:ADS) €220.50 €433.62 49.1% Clemondo Group (OM:CLEM) SEK10.80 SEK21.24 49.2% Absolent Air Care Group (OM:ABSO) SEK215.00 SEK416.92 48.4% Lectra (ENXTPA:LSS) €24.75 €47.27 47.6% dormakaba Holding (SWX:DOKA) CHF733.00 CHF1399.64 47.6% Claranova (ENXTPA:CLA) €2.805 €5.45 48.5% Northern Data (DB:NB2) €25.02 €49.53 49.5% Click here to see the full list of 182 stocks from our Undervalued European Stocks Based On Cash Flows screener. Let's dive into some prime choices out of the screener. Overview: A.L.A. società per azioni is a supply chain solutions provider serving the aerospace and defense, rail, and high-tech sectors with a market cap of €314.24 million. Operations: The company's revenue is primarily derived from its Distribution segment at €140.29 million, followed by Service Providers at €120.54 million, Production at €23.15 million, and On Site Assembly at €5.91 million. Estimated Discount To Fair Value: 26.7% A.L.A. società per azioni is trading at €34.8, significantly below its estimated fair value of €47.49, reflecting a potential undervaluation based on cash flows. Despite a high level of non-cash earnings and debt not well covered by operating cash flow, the company's earnings grew 71.7% last year and are forecast to grow 22.3% annually, outpacing the Italian market's growth rate of 7.4%. Our earnings growth report unveils the potential for significant increases in A.L.A. società per azioni's future results. Click here and access our complete balance sheet health report to understand the dynamics of A.L.A. società per azioni. Overview: Datalogic S.p.A. is a company that produces and distributes automatic data capture and process automation products across various regions including Italy, the Americas, the Asia Pacific, Europe, the Middle East, and Africa with a market cap of €248.65 million. Operations: Datalogic's revenue is primarily derived from two segments: Data Capture, contributing €338.70 million, and Industrial Automation, generating €156.49 million. Estimated Discount To Fair Value: 15% Datalogic is trading at €4.64, 15% below its estimated fair value of €5.45, indicating potential undervaluation based on cash flows. Despite a recent quarterly net loss of €5.86 million and declining profit margins, earnings are projected to grow significantly at 57.72% annually over the next three years, outpacing both revenue growth and the Italian market's earnings growth rate of 7.4%. However, its dividend yield of 2.59% is not well covered by earnings or free cash flows. According our earnings growth report, there's an indication that Datalogic might be ready to expand. Unlock comprehensive insights into our analysis of Datalogic stock in this financial health report. Overview: Cicor Technologies Ltd., along with its subsidiaries, develops and manufactures electronic components, devices, and systems globally, with a market cap of CHF548.70 million. Operations: The company's revenue segments include the Advanced Substrates (AS) Division, generating CHF45.31 million, and the Electronic Manufacturing Services (EMS) Division, contributing CHF438.01 million. Estimated Discount To Fair Value: 12.2% Cicor Technologies, trading at CHF126, is slightly undervalued based on discounted cash flow analysis with an estimated fair value of CHF143.47. Despite recent shareholder dilution and high share price volatility, earnings are expected to grow significantly at 21.48% annually over the next three years, surpassing Swiss market averages. Recent strategic moves include a supply agreement with Mercury Mission Systems to enhance its European aerospace and defense presence, potentially boosting future revenue streams. Insights from our recent growth report point to a promising forecast for Cicor Technologies' business outlook. Take a closer look at Cicor Technologies' balance sheet health here in our report. Click through to start exploring the rest of the 179 Undervalued European Stocks Based On Cash Flows now. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:ALA BIT:DAL and SWX:CICN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
